Full Press Release Details
SAN DIEGO, Aug. 26, 2015 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the following upcoming investor conferences:
The presentations will be webcast live, and an archive recording will be available for 30 days. The links to the live webcasts and archives will be accessible on Tandem Diabetes Care's Investor Center website located athttp://investor.tandemdiabetes.comin the "Investor Events" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, and the t:flex™ Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on:
Twitter @tandemdiabetes, use #tslim, #tflex, #tconnect and $TNDM.
Facebook atwww.facebook.com/TandemDiabetes
LinkedIn atwww.linkedin.com/company/TandemDiabetes
t:flex is a trademark, and t:slim and Tandem Diabetes Care are registered trademarks of Tandem Diabetes Care, Inc.